Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cann Group ( (AU:CAN) ) has shared an announcement.
Cann Group Limited has announced a short-term extension of its debt facilities with National Australia Bank, moving the expiry date from 15 October 2025 to 31 October 2025. This extension allows the company additional time to engage in refinancing discussions and evaluate options that align with its long-term financial strategy, potentially impacting its operational stability and financial planning.
More about Cann Group
Cann Group Limited is a company focused on enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. It operates research facilities and a large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. The company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and globally. Cann Group also owns Satipharm and its patent-protected capsule technology.
YTD Price Performance: -61.54%
Average Trading Volume: 2,337,745
Technical Sentiment Signal: Sell
Current Market Cap: A$10.91M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.